Pnc Financial Services Group, Inc. Regeneron Pharmaceuticals, Inc. Transaction History
Pnc Financial Services Group, Inc.
- $162 Billion
- Q3 2025
A detailed history of Pnc Financial Services Group, Inc. transactions in Regeneron Pharmaceuticals, Inc. stock. As of the latest transaction made, Pnc Financial Services Group, Inc. holds 17,316 shares of REGN stock, worth $12 Million. This represents 0.01% of its overall portfolio holdings.
Number of Shares
17,316
Previous 14,715
17.68%
Holding current value
$12 Million
Previous $7.73 Million
26.03%
% of portfolio
0.01%
Previous 0.01%
Shares
33 transactions
Others Institutions Holding REGN
# of Institutions
1,466Shares Held
86.5MCall Options Held
2.38MPut Options Held
1.61M-
Vanguard Group Inc Valley Forge, PA9.05MShares$6.27 Billion0.08% of portfolio
-
Black Rock Inc. New York, NY8.45MShares$5.86 Billion0.2% of portfolio
-
State Street Corp Boston, MA4.69MShares$3.25 Billion0.09% of portfolio
-
Dodge & Cox San Francisco, CA4.55MShares$3.16 Billion1.47% of portfolio
-
Jpmorgan Chase & CO New York, NY4.07MShares$2.82 Billion0.15% of portfolio
About REGENERON PHARMACEUTICALS, INC.
- Ticker REGN
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 107,190,000
- Market Cap $74.3B
- Description
- Regeneron Pharmaceuticals, Inc. discovers, invents, develops, manufactures, and commercializes medicines for treating various diseases worldwide. The company's products include EYLEA injection to treat wet age-related macular degeneration and diabetic macular edema; myopic choroidal neovascularization; and diabetic retinopathy, as well as macula...